Veno-occlusive disease of the liver after bone marrow transplantation
Increased soluble P-selectin following myocardial infarction
Plasma levels of thrombomodulin and lipoprotein (a) in patients with cerebral thrombosis
Inherited abnormalities of blood coagulation in juvenile stroke. A case-control study
Insight into the profibrinolytic activity of heparin
Assessment of mental ability in elderly anticoagulated patients
A comparison between continuous infusion versus standard bolus administration of heparin based on monitoring in cardiac surgery
Influence of plasma volumetric errors on the prothrombin time ratio and International Sensitivity Index
Recurrent venous thromboembolic disease and factor XI concentrate in a patient with severe factor XI deficiency, chronic myelomonocytic leukaemia, factor V Leiden and heterozygous plasminogen deficiency
Fibrinogen Poissy I
Variant of intron 22 inversions in the factor VIII gene in severe hemophilia A
Natural anticoagulation with thrombocytopenia may spare the thromboembolic complications in severe cyanotic congenital heart disease
British Society for Haemostasis and Thrombosis
British Society for Haemostasis and Thrombosis 15–17 September 1997 Aberdeen, UK
Whole blood flow cytometric analysis of plateletleucocyte aggregates
Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor γ-chain
Intra-vascular oxygen delivery by novel perfluorochemical emulsions
Haematological predictors of thrombosis
Admission prothrombin fragment F1 + 2 levels and mortality in acute coronary syndromes
Changes in APC sensitivity ratio and other haemostatic parameters following DDAVP infusion
Thermolabile methylenetetrahydrofolate reductase genotypes and homocysteine analysis in patients with venous thromboembolic disease
Superficial vein thrombosis
Epidemiology of activated protein C resistance, APTT and factor V Leiden
A cell model for studies on the function of the endothelial protein C receptor
Regulation of the plasminogen system by glucose and transforming growth factor-β in cultured human retinal endothelial cells
Binding of tPA to human vascular smooth muscle cells
Thrombin-activatable plasminogen
Modulation of haemostasis in leeches, nature's most successful phlebotomists
Plasminogen activator inhibitor-2 from peripheral blood monocytes cross-links to fibrin, where it retains its inhibitory activity
Clinical correlation and prognostic implication of clot waveform analysis in severely ill patients
Dietary essential fatty acid supplementation in young patients with insulin-dependent diabetes mellitus attenuates endothelial activation and/or damage
Factor X Nottingham
The PlA2 polymorphism in human platelet membrane GPIIIa is associated with increased fibrinogen binding to stimulated platelets
Prevalence of the prothrombin gene G20210A variant in an UK anticoagulant clinic population
Precise carrier and prenatal diagnosis in families with haemophilia A facilitated by conformational sensitive gel electrophoresis for mutation screening and polymorphism analysis
Single stranded conformational polymorphism screening for von Willebrand disease type 2N mutations
Interference on FXI
Oxidative stress in primary antiphospholipid syndrome
The use of a HUVEC cDNA library to investigate the specificity of anti-endothelial cell antibodies in primary APS
Haemostasis and thrombosis in mice with genetic deficits in coagulation and fibrinolysis
Haemostatic derangements and major sepsis
Tissue immunolocalisation of endothelium reactive autoantibody in the primary antiphospholipid syndrome
Serum from patients with primary antiphospholipid syndrome contains platelet recognising antibodies but does not enhance either microparticle formation or alpha-granule secretion by normal platelets
Platelet activation markers in patients with the antiphospholipid syndrome
P1 The effect of exercise followed by moderate alcohol ingestion on blood coagulation and fibrinolysis into recovery
P2 Evaluation of the PFA-100™ system
P3 A patient with high molecular weight kininogen deficiency who underwent cardiopulmonary bypass surgery
P4 Progressive decrease in platelet function of buffy coat derived platelet concentrates
P5 Computer-assisted dosing of oral anticoagulants
P6 Prognostic value of haemostatic variables in acute ischaemic stroke
P7 Alterations of haemostatic markers in subtypes of acute vascular stroke
P8 One-stage clotting assays are unsuitable for the determination of FXII levels in patients with phospholipid antibodies
P9 Prekallikrein levels in a population of blood donors
P10 Does pressure/decompression or intravascular gas bubble formation following simulated air saturation dives activate haemostasis? A pilot study
P11 Haemostasis and rheology in vascular dementia and stroke
P12 Antithrombin affinity fractionation of unfractionated and low molecular weight heparins
P13 Markers of endothelial cell damage and oxidative stress in juvenile diabetics
P14 Antiendothelial cell as well as antiphospholipid antibodies are a feature of recurrent miscarriage
P15 A normal range for activated protein C resistance in the third trimester of pregnancy
P16 Comparison of the effect of the venom from the Australian (Oxyuranus scutellatus scutellatus) and Papuan taipan (Oxyuranus scutellatus canni) sub-species on haemostasis
P17 Plasminogen activator inhibitor-2 (PAI-2) in plasma and white cells from normal and severely septicaemic subjects
P18 Haemostatic changes induced in 84 humans bitten by the Papuan taipan (Oxyuranus scutellatus canni) and recovery following antivenom